Home › Funds › UBS Group AG › LBPH
UBS Group AG position in LBPH
LONGBOARD PHARMACEUTICALS IN
Latest position (Q3 2024)37.30K sh
Reported value held$1.24M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.43K | $13.00K | New |
| Q2 2022 | 64 | $0 | New |
| Q4 2022 | 971 | $3.17K | New |
| Q1 2023 | 528 | $2.12K | Reduce |
| Q2 2023 | 9.06K | $66.49K | Add |
| Q3 2023 | 8.29K | $46.07K | Reduce |
| Q4 2023 | 15.24K | $91.89K | Add |
| Q1 2024 | 39.11K | $844.86K | Add |
| Q2 2024 | 30.14K | $814.71K | Reduce |
| Q3 2024 | 37.30K | $1.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.